New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
The latest product approvals and launches.
You may also be interested in...
Financings In Brief
GenMark Diagnostics prices $42 million secondary offering. Oxford Immunotec raises $28 million for TB test commercialization efforts. Benvenue Medical gets $25 million for spinal devices. More financings.
New Products In Brief
Recent product approvals and launches
DFine's STAR Spinal Tumor Ablation System To Hit U.S. Market In Q4
DFine plans to begin a gradual commercial launch late this year of its STAR system, designed to help cancer patients suffering from painful metastases in the spine.